Tumor microenvironment composition strongly conditions cancer growth and progression, acting not only at cancer itself but also modifying its interactions with immune, endothelial and nervous cells. Extracellular ATP and its receptors recently gained increasing attention in the oncological field. ATP accumulates in cancer milieu through spontaneous release, tumor necrosis or chemotherapy exerting a trophic activity on cancer cells, modulating the cross talk among tumor, and surrounding tissues. Accordingly, ATP gated P2X receptors emerged as central players in tumor development, invasion, progression and related symptoms. Indeed, P2X receptors are expressed and are functional not only on tumor cells but also in immune-infiltrate and nearby ...
The purinergic P2X7 receptor (P2X7R) is a transmembrane protein whose expression has been related to...
Objectives/background: The P2X7 receptor for extracellular ATP recently emerged as regulator of ca...
Modulation of the biochemical composition of the tumour microenvironment is a new frontier of cancer...
It is increasingly appreciated that ion channels have a crucial role in tumors, either as promoters ...
The P2X7 receptor for extracellular ATP has long being known as ion channel involved in Interleukin ...
Extracellular ATP (eATP) is a key mediator of the immune response and it is one of the components of...
The P2X(7) receptor is widely referred to as the paradigmatic cytotoxic nucleotide receptor, and is ...
P2X7 is a transmembrane receptor expressed in multiple cell types including neurons, dendritic cells...
Tumor microenvironment is nucleoside and nucleotide rich. Adenosine is a key determinant of the high...
The P2X7 receptor is an ATP-gated ion channel known for its cytotoxic activity. However, recent evid...
P2X7 is an intriguing ionotropic receptor for which the activation by extracellular ATP induces rapi...
The P2X7 receptor is an ATP-gated ion channel known for its cytotoxic activity. However, recent evid...
AbstractP2X7 is an intriguing ionotropic receptor for which the activation by extracellular ATP indu...
Symptoms associated with lung cancer mainly consist of cancer-associated pain, cough, fatigue, and d...
International audienceDespite new biological insights and recent therapeutic advances, many tumors r...
The purinergic P2X7 receptor (P2X7R) is a transmembrane protein whose expression has been related to...
Objectives/background: The P2X7 receptor for extracellular ATP recently emerged as regulator of ca...
Modulation of the biochemical composition of the tumour microenvironment is a new frontier of cancer...
It is increasingly appreciated that ion channels have a crucial role in tumors, either as promoters ...
The P2X7 receptor for extracellular ATP has long being known as ion channel involved in Interleukin ...
Extracellular ATP (eATP) is a key mediator of the immune response and it is one of the components of...
The P2X(7) receptor is widely referred to as the paradigmatic cytotoxic nucleotide receptor, and is ...
P2X7 is a transmembrane receptor expressed in multiple cell types including neurons, dendritic cells...
Tumor microenvironment is nucleoside and nucleotide rich. Adenosine is a key determinant of the high...
The P2X7 receptor is an ATP-gated ion channel known for its cytotoxic activity. However, recent evid...
P2X7 is an intriguing ionotropic receptor for which the activation by extracellular ATP induces rapi...
The P2X7 receptor is an ATP-gated ion channel known for its cytotoxic activity. However, recent evid...
AbstractP2X7 is an intriguing ionotropic receptor for which the activation by extracellular ATP indu...
Symptoms associated with lung cancer mainly consist of cancer-associated pain, cough, fatigue, and d...
International audienceDespite new biological insights and recent therapeutic advances, many tumors r...
The purinergic P2X7 receptor (P2X7R) is a transmembrane protein whose expression has been related to...
Objectives/background: The P2X7 receptor for extracellular ATP recently emerged as regulator of ca...
Modulation of the biochemical composition of the tumour microenvironment is a new frontier of cancer...